![Intensive insulin for type 2 diabetes: the risk of causing harm - The Lancet Diabetes & Endocrinology Intensive insulin for type 2 diabetes: the risk of causing harm - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/2009246086/2032058106/gr1.jpg)
Intensive insulin for type 2 diabetes: the risk of causing harm - The Lancet Diabetes & Endocrinology
![Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes | SpringerLink Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-018-4603-5/MediaObjects/125_2018_4603_Figa_HTML.gif)
Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes | SpringerLink
Short- and long-term effects of a need-supportive physical activity intervention among patients with type 2 diabetes mellitus: A randomized controlled pilot trial | PLOS ONE
![Type 2 Diabetes Mellitus Treatment & Management: Approach Considerations, Pharmacologic Therapy, Management of Glycemia Type 2 Diabetes Mellitus Treatment & Management: Approach Considerations, Pharmacologic Therapy, Management of Glycemia](https://img.medscapestatic.com/pi/meds/ckb/01/30201tn.jpg)
Type 2 Diabetes Mellitus Treatment & Management: Approach Considerations, Pharmacologic Therapy, Management of Glycemia
![Intermittent fasting has short-term effects on albuminuria, AGE formation and acylcarnitines in patients with type 2 diabetes - Media Centre | EASD Intermittent fasting has short-term effects on albuminuria, AGE formation and acylcarnitines in patients with type 2 diabetes - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/1113_764487/Slide1.jpg)